Marine Calcium Tablet
Natural health product licensed in Canada
- Licence holder
- Canpower health inc.
- NPN or DIN-HM
- 80147942
- Status
- Active licence
- Licence date
- 18 March 2026
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 24.975 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Phymatolithon calcareum - entier | 250 mg | 750,000 µg |
| Magnésium Source : Citrate de magnésium | 21 mg | 63,000 µg |
| Vitamine K2 Source : Ménaquinone 7 | 40 Microgrammes | Not calculated |
| Vitamine D Source : Ergocalciférol | 333 UI | 24.975 µg |
| Vitamine D Source : Ergocalciférol | 8.33 Microgrammes | Not calculated |
Non-medicinal ingredients
Poly(dextrose), Croscarmellose de sodium, Cellulose microcristalline, Maltodextrine, Amidon de maïs, Hypromellose, Dioxyde de silicium, NA, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the absorption (and use) of calcium and phosphorus. Helps in the development and maintenance of bones/(and) teeth. Helps in the maintenance of bones. Helps to maintain/support normal muscle function. Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps maintain/support bone health. As part of a healthy diet (when taken with Vitamin D) may help prevent bone loss/osteoporosis. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) (in later life).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80147942
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.